» Authors » Cosimo Franco

Cosimo Franco

Explore the profile of Cosimo Franco including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 191
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Casella G, Salemi B, Franco C, Acampora M, Barello S, Guasconi M
Acta Biomed . 2023 Dec; 94(6):e2023248. PMID: 38054671
Background And Aim: Chronic obstructive pulmonary disease (COPD) is a disease characterized by persistent respiratory symptoms and airflow limitation. COPD is a significant social and economic burden, and hospital admissions...
2.
Colombi D, Petrini M, Risoli C, Mangia A, Milanese G, Silva M, et al.
Diagnostics (Basel) . 2023 Nov; 13(21). PMID: 37958224
Background: The role of quantitative chest computed tomography (CT) is controversial in the follow-up of patients with COVID-19 pneumonia. The aim of this study was to test during the follow-up...
3.
Colombi D, Adebanjo G, Delfanti R, Chiesa S, Morelli N, Capelli P, et al.
Life (Basel) . 2023 Jun; 13(6). PMID: 37374159
Background: to test the association with overall survival (OS) of low attenuation areas (LAAs) quantified by staging computed tomography (CT) of patients who underwent radical surgery for nonsmall-cell lung cancer...
4.
Colombi D, Risoli C, Delfanti R, Chiesa S, Morelli N, Petrini M, et al.
Life (Basel) . 2023 Jan; 13(1). PMID: 36676147
Background: To test the agreement between postoperative pulmonary function tests 12 months after surgery (mpo-PFTs) for non-small cell lung cancer (NSCLC) and predicted lung function based on the quantification of...
5.
Salton F, Confalonieri P, Centanni S, Mondoni M, Petrosillo N, Bonfanti P, et al.
Eur Respir J . 2022 Nov; 61(4). PMID: 36356972
Background: Dysregulated systemic inflammation is the primary driver of mortality in severe coronavirus disease 2019 (COVID-19) pneumonia. Current guidelines favour a 7-10-day course of any glucocorticoid equivalent to dexamethasone 6 ...
6.
Chetta A, Facciolongo N, Franco C, Franzini L, Piraino A, Rossi C
Ther Clin Risk Manag . 2022 Oct; 18:965-979. PMID: 36212050
In recent years, the perspective of management of respiratory disease has been gradually changing in light of the increasing evidence of small airways as the major site of airflow obstruction...
7.
Colombi D, Petrini M, Rapacioli F, Bodini F, Chiesa S, Franco C, et al.
Tumori . 2022 Mar; 109(2):215-223. PMID: 35341397
Objective: To describe in non-small cell lung cancer (NSCLC) the impact of visceral pleural invasion (VPI) and of tumor sizing assessed at computed tomography (CT) on the agreement between clinical-radiological...
8.
Cavanna L, Citterio C, Toscani I, Franco C, Magnacavallo A, Caprioli S, et al.
Future Sci OA . 2021 Jan; 7(1):FSO645. PMID: 33432270
Background: Cancer patients are considered a highly fragile group in the current coronavirus disease 2019 (COVID-19) pandemic. Material & Methods: In this study, patients with COVID-19 and cancer, hospitalized in...
9.
Cattaruzza M, Gorini G, Bosetti C, Boffi R, Lugo A, Veronese C, et al.
Acta Biomed . 2020 Sep; 91(3):e2020062. PMID: 32921714
The emergency caused by Covid-19 pandemic raised interest in studying lifestyles and comorbidities as important determinants of poor Covid-19 prognosis. Data on tobacco smoking, alcohol consumption and obesity are still...
10.
Franco C, Facciolongo N, Tonelli R, Dongilli R, Vianello A, Pisani L, et al.
Eur Respir J . 2020 Aug; 56(5). PMID: 32747398
Introduction: The severe acute respiratory syndrome-coronavirus 2 outbreak spread rapidly in Italy and the lack of intensive care unit (ICU) beds soon became evident, forcing the application of noninvasive respiratory...